DE3029421C2 - - Google Patents
Info
- Publication number
- DE3029421C2 DE3029421C2 DE3029421A DE3029421A DE3029421C2 DE 3029421 C2 DE3029421 C2 DE 3029421C2 DE 3029421 A DE3029421 A DE 3029421A DE 3029421 A DE3029421 A DE 3029421A DE 3029421 C2 DE3029421 C2 DE 3029421C2
- Authority
- DE
- Germany
- Prior art keywords
- chloridarol
- activity
- lipidemia
- cloridarol
- clofibrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- KBFBRIPYVVGWRS-UHFFFAOYSA-N cloridarol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C1=CC=C(Cl)C=C1 KBFBRIPYVVGWRS-UHFFFAOYSA-N 0.000 claims description 8
- 229960001261 cloridarol Drugs 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 2
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 2
- 229960001214 clofibrate Drugs 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000011102 Thera Species 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT7909513A IT1207887B (it) | 1979-08-10 | 1979-08-10 | Uso in terapia del prodotto (2benzofuril)-(p-clorofenil)-carbino lo(cloridarol dci)come normolipide mizzante e antiaggregante piastrinico |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3029421A1 DE3029421A1 (de) | 1981-02-26 |
| DE3029421C2 true DE3029421C2 (enExample) | 1990-02-22 |
Family
ID=11131363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19803029421 Granted DE3029421A1 (de) | 1979-08-10 | 1980-08-02 | Verwendung von cloridarol zur behandlung der lipidaemie und als antikoagulans |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4296124A (enExample) |
| JP (1) | JPS5645413A (enExample) |
| BE (1) | BE884691A (enExample) |
| CA (1) | CA1155395A (enExample) |
| CH (1) | CH648756A5 (enExample) |
| DE (1) | DE3029421A1 (enExample) |
| FR (1) | FR2463135A1 (enExample) |
| GB (1) | GB2056280A (enExample) |
| IT (1) | IT1207887B (enExample) |
| LU (1) | LU82700A1 (enExample) |
| NL (1) | NL8004534A (enExample) |
| ZA (1) | ZA804822B (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1160925A (en) * | 1967-02-08 | 1969-08-06 | Menarini Sas | 2-Substituted Benzofuran Derivatives |
-
1979
- 1979-08-10 IT IT7909513A patent/IT1207887B/it active
-
1980
- 1980-08-01 GB GB8025197A patent/GB2056280A/en not_active Withdrawn
- 1980-08-02 DE DE19803029421 patent/DE3029421A1/de active Granted
- 1980-08-07 ZA ZA00804822A patent/ZA804822B/xx unknown
- 1980-08-08 LU LU82700A patent/LU82700A1/fr unknown
- 1980-08-08 BE BE0/201683A patent/BE884691A/fr not_active IP Right Cessation
- 1980-08-08 JP JP10839080A patent/JPS5645413A/ja active Granted
- 1980-08-08 CH CH6040/80A patent/CH648756A5/it not_active IP Right Cessation
- 1980-08-08 NL NL8004534A patent/NL8004534A/nl not_active Application Discontinuation
- 1980-08-11 CA CA000357982A patent/CA1155395A/en not_active Expired
- 1980-08-11 FR FR8017691A patent/FR2463135A1/fr active Granted
- 1980-08-11 US US06/176,867 patent/US4296124A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB2056280A (en) | 1981-03-18 |
| US4296124A (en) | 1981-10-20 |
| CA1155395A (en) | 1983-10-18 |
| DE3029421A1 (de) | 1981-02-26 |
| CH648756A5 (it) | 1985-04-15 |
| NL8004534A (nl) | 1981-02-12 |
| IT1207887B (it) | 1989-06-01 |
| BE884691A (fr) | 1980-12-01 |
| LU82700A1 (fr) | 1980-12-15 |
| FR2463135B1 (enExample) | 1983-08-12 |
| ZA804822B (en) | 1981-08-26 |
| JPH0153244B2 (enExample) | 1989-11-13 |
| FR2463135A1 (fr) | 1981-02-20 |
| IT7909513A0 (it) | 1979-08-10 |
| JPS5645413A (en) | 1981-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3507024C2 (de) | Lösung zur Augenbehandlung | |
| DE3005208A1 (de) | Verwendung von acylcarnitin in arzneimitteln zur behandlung von stoerungen im gehirn-metabolismus | |
| DE69027220T2 (de) | Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen | |
| CH695983A5 (de) | Tetraiodthyropropionsäure oder Tetraiodthyroessigsäure zur Herstellung eines dermatologischen Präparates. | |
| EP0869807B1 (de) | Anwendung eines medikaments und verwendung eines stoffgemischs zur herstellung eines medikaments | |
| DE2206570C3 (de) | Verwendung von (+)-Catechin | |
| DE2824165A1 (de) | Arzneimittel mit angstneurosen und angstaehnliche neurosen beseitigender wirkung und verfahren zum zubereiten des arzneimittels | |
| CH638681A5 (en) | Pharmaceutical containing Echinacea and lactic acid derivatives and process for its preparation | |
| DE69131517T2 (de) | Verwendung von Prostaglandin-E1 zur Behandlung männlicher erektiler Impotenz | |
| DE19726871C1 (de) | Synergistisch wirkende Zusammensetzungen zur selektiven Bekämpfung von Tumorgewebe | |
| DE2326301C2 (de) | Pharmazeutische Zusammensetzung, enthaltend Askorbinsäure und eine Vincaminverbindung | |
| EP0256385B1 (de) | Verwendung von 15-Deoxyspergualin als Arzneimittel | |
| DE3035480A1 (de) | Pharmazeutische zusammensetzung zur behandlung von herzstoerungen | |
| DE2820808C2 (enExample) | ||
| DE3728367C1 (de) | Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen | |
| DE3029421A1 (de) | Verwendung von cloridarol zur behandlung der lipidaemie und als antikoagulans | |
| DE2801867A1 (de) | Antikoagulans-arzneimittel auf der basis von heparin | |
| EP1492546B1 (de) | Verwendung von pyrimidinnukleotiden zur behandlung von schaedigungen des peripheren nervensystems | |
| DE1617508C3 (de) | Antidepressive Mittel | |
| DE3519736C2 (de) | Mittel zur Behandlung von Rheuma und Polyarthritis | |
| DE3043909A1 (de) | Arzneimittel, enthaltend eine kombination von acetylsalicylsaeure und heptaminol | |
| EP0002803B1 (de) | Cis-(3,3,5)-Trimethylcyclohexanol zur Verwendung bei der Behandlung von Galleleiden | |
| DE1806400A1 (de) | Pharmazeutisches Produkt,insbesondere injizierbares Lakalanaesthetikum | |
| CH644374A5 (en) | Water-soluble hydroxyflavone ethers and medicaments containing them | |
| DE1467743A1 (de) | Verfahren zur Herstellung eines Praeparats mit verlaengerter Vitamin B 12-Wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |